Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > CVS rolling out home.

<< Previous

Bullboard Posts

Next >>

Post by oilandgasmanon Dec 20, 2021 2:27pm

252 Views

Post# 34247762

CVS rolling out home.

Without a approved machine or so it looks.
The status of the DEKA trial is elusive from what I’ve found..Looks as if they've recently removed the info on the trial from the DEKA site.

See below.

https://www.healio.com/news/nephrology/20190820/first-patient-begins-cvs-trial-with-dean-kamendesigned-home-dialysis-machine

CVS rollout/ no mention of a device..Also CVS plans in center treatments.

https://www.healio.com/news/nephrology/20190820/first-patient-begins-cvs-trial-with-dean-kamendesigned-home-dialysis-machine

CVS may be a player here.

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter